Key result
Oral propafenone administration in a man with a history of malignant ventricular arrhythmias resulted in incessant ventricular tachycardia and subsequent death within several hours.
Case Report (n=1)
Propafenone, a class IC antiarrhythmic agent, can have severe proarrhythmic effects leading to fatal ventricular tachycardia in patients with prior myocardial infarction and ventricular arrhythmias.
Answers are grounded in this paper and cite their sources.
Alerts clinicians to possible fatal proarrhythmia with propafenone in patients with malignant ventricular arrhythmias; single case leaves open population-level risk.
A man with a past history of malignant ventricular arrhythmias occurring late after myocardial infarction was admitted for assessment. Monitoring revealed frequent ventricular premature beats and occasional non-sustained runs of ventricular tachycardia. Other drugs having failed, he was started on oral propafenone which is a new Vaughan Williams class IC antiarrhythmic agent. Several hours after starting this drug he had incessant ventricular tachycardia and subsequently died. Other class IC agents have been shown to have a high incidence of proarrhythmic effects, and particular care should be taken with these potent new drugs.
No takes yet. Share an insight, caveat, or question.
Nathan et al. (1984) conducted a case report in Malignant ventricular arrhythmias late after myocardial infarction (n=1). Oral propafenone was evaluated on Incessant ventricular tachycardia and death. Oral propafenone administration in a man with a history of malignant ventricular arrhythmias resulted in incessant ventricular tachycardia and subsequent death within several hours.
Synapse has enriched 10 related papers. Consider them for comparative context: